Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Radiation Oncology/Therapy
Study questions routine use of radiotherapy after bone surgery
By
Will Morton
Findings suggest a possible hazard associated with postoperative radiotherapy.
February 13, 2026
Siemens, Northwestern to collaborate on precision cancer care
By
AuntMinnie.com staff writers
The two organizations plan to establish a global center of excellence in theranostics.
February 9, 2026
Public-private EU consortium awarded $18M for cancer research
By
AuntMinnie.com staff writers
The PreciseOnco consortium has been awarded $17.6 million from the EU’s Innovative Health Initiative for precision cancer treatment.
February 4, 2026
ASTRO and ESTRO mark World Cancer Day
By
AuntMinnie.com staff writers
Today’s radiotherapy is a far more precise, effective, and patient-centered treatment than ever before, according to the groups.
February 4, 2026
Nucs AI establishes medical advisory board
By
AuntMinnie.com staff writers
Nucs AI has formed its medical advisory board to ensure the company's AI theranostics tech is aligned with clinical practice.
January 29, 2026
ASTRO launches national radiopharmaceutical therapy training centers
By
AuntMinnie.com staff writers
ASTRO has launched a national program creating Authorized User Training Centers for radiopharmaceutical therapy education.
January 29, 2026
Nuclidium wins patent for Cu-61-based radiodiagnostic program
By
AuntMinnie.com staff writers
The patent protects the copped-61 (Cu-61)-based diagnostic as well as its use in combination with Cu-67.
January 26, 2026
Elekta secures U.S. FDA 510(k) clearance for Evo
By
AuntMinnie.com staff writers
The company is moving forward with Elekta Evo CT-Linac.
January 16, 2026
Alliance for Clinical Trials in Oncology launches prostate cancer trial
By
AuntMinnie.com staff writers
The phase III trial, called RECIPROCAL, will include 1,500 patients with metastatic, castration-resistant prostate cancer.
January 5, 2026
What are Pluvicto discontinuation rates in a real-world setting?
By
Will Morton
There is a critical need to predict nonresponders and potential discontinuers prior to treatment.
January 5, 2026
ASTRO introduces new research foundation approach
By
AuntMinnie.com staff writers
ASTRO is renaming its research foundation and highlighting new aims for the institute to go along with the update.
January 2, 2026
Proton therapy effective for patients with oropharyngeal cancer
By
Will Morton
The treatment targets tumors with charged particles rather than the high-energy x-rays of photon therapy.
December 15, 2025
Page 1 of 468
Next Page